POWER OF KNOWLEDGE

Insight Center: News

Pepper Hamilton Represents Aclaris Therapeutics during Acquisition of Confluence Life Sciences, Inc.

Health Science Attorneys Serve as Counsel during Acquisition of Privately Held Biotech Company

8/16/2017
Pepper Hamilton Represents Aclaris Therapeutics during Acquisition of Confluence Life Sciences, Inc.

Aclaris, a Malvern-based dermatologist-led biopharmaceutical company, recently announced that it has acquired Confluence Life Sciences, Inc., a privately held biotechnology company focused on the development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. Pepper Hamilton represented Aclaris in the transaction.

The acquisition will strengthen Aclaris’ inflammation and immunology treatment research capabilities through Confluence’s drug discovery platform and kinase inhibitor program.

Pepper attorneys who provided counsel include:

  • Shirley Kuhlmann, partner in the firm’s Health Sciences Department

  • Nicole Stakleff, partner in the firm’s Health Sciences Department

  • Ray Miller, partner and member of the Leadership Team in the firm’s Health Sciences Department

  • Michael Crumbock, partner in the firm’s Employee Benefits Practice Group

  • David Stauber, of counsel in the firm’s Tax Practice Group

  • Yason Allie, associate in the firm’s Corporate and Securities Practice Group

Contact:
Amanda Mueller
610.228.4071
Amanda.mueller@buchananpr.com